VASP Produits
(Vasodilator-Stimulated phosphoprotein (VASP))
Catégories
Vasodilator-stimulated phosphoprotein (VASP) is a member of the Ena-VASP protein family. Ena-VASP family members contain an EHV1 N-terminal domain that binds proteins containing E/DFPPPPXD/E motifs and targets Ena-VASP proteins to focal adhesions. In the mid-region of the protein, family members have a proline-rich domain that binds SH3 and WW domain-containing proteins. Their C-terminal EVH2 domain mediates tetramerization and binds both G and F actin. VASP is associated with filamentous actin formation and likely plays a widespread role in cell adhesion and motility. VASP may also be involved in the intracellular signaling pathways that regulate integrin-extracellular matrix interactions. VASP is regulated by the cyclic nucleotide-dependent kinases PKA and PKG. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories VASP en vedette
VASP Anticorps
High quality antibodies with extensive validation data.
VASP Kits ELISA
Reliable ELISA kits for a wide range of species.
VASP Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
VASP recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Mouse, Rat
Application
IHC
Validations
- (5)
N° du produit
ABIN7257730
Quantité
200 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, IF
Validations
- (5)
N° du produit
ABIN6150064
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, IP
Validations
- (5)
N° du produit
ABIN6136286
Quantité
100 μL
Fiche technique
Fiche technique
VASP recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Rat
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
- (1)
N° du produit
ABIN6960472
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6971136
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6960471
Quantité
96 tests
Fiche technique
Fiche technique
VASP recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
N° du produit
ABIN7125705
Quantité
50 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1324923
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Rat
Source
Escherichia coli (E. coli)
Validations
N° du produit
ABIN7413274
Quantité
100 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits VASP
: "Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells." dans: Acta pharmacologica Sinica, Vol. 38, Issue 1, pp. 41-55, (2016) (PubMed).: "Quantitative Proteomics Analysis Reveals Novel Insights into Mechanisms of Action of Long Noncoding RNA Hox Transcript Antisense Intergenic RNA (HOTAIR) in HeLa Cells." dans: Molecular & cellular proteomics : MCP, Vol. 14, Issue 6, pp. 1447-63, (2015) (PubMed).
: "Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy." dans: Journal of proteomics, Vol. 75, Issue 7, pp. 2236-51, (2012) (PubMed).
: "Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist." dans: Arteriosclerosis, thrombosis, and vascular biology, Vol. 31, Issue 2, pp. 416-22, (2011) (PubMed).
: "Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration." dans: Oncology reports, Vol. 26, Issue 6, pp. 1609-15, (2011) (PubMed).
: "Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury." dans: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 23, Issue 12, pp. 4244-55, (2009) (PubMed).
: "Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins." dans: Neuron, Vol. 45, Issue 3, pp. 389-403, (2005) (PubMed).
: "Structural basis of filopodia formation induced by the IRSp53/MIM homology domain of human IRSp53." dans: The EMBO journal, Vol. 24, Issue 2, pp. 240-50, (2005) (PubMed).
: "The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 49, pp. 17027-32, (2004) (PubMed).
: "Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide." dans: Blood, Vol. 104, Issue 9, pp. 2775-82, (2004) (PubMed).
Synonymes et noms alternatifs relatifs à VASP
vasodilator stimulated phosphoprotein S homeolog (vasp.S), vasodilator stimulated phosphoprotein b (vaspb), protein enabled (LOC5573842), vasodilator-stimulated phosphoprotein (CpipJ_CPIJ004706), vasodilator-stimulated phosphoprotein (CpipJ_CPIJ004707), vasodilator-stimulated phosphoprotein (vasP), vasodilator-stimulated phosphoprotein (vasp), vasodilator-stimulated phosphoprotein (VASP), vasodilator stimulated phosphoprotein a (vaspa), vasodilator stimulated phosphoprotein (VASP), vasodilator-stimulated phosphoprotein (Vasp), DDBDRAFT_0188463, DDBDRAFT_0229340, DDB_0188463, DDB_0229340, MGC80889, si:ch211-202c21.1, si:dkey-113g17.1, vasp, VASP, wu:fb23b04, wu:fk84g05, zgc:110347Protein level used designations for VASP
- vasodilator-stimulated phosphoprotein
- Vasodilator-stimulated phosphoprotein
Avez-vous cherché autre chose?
Vous êtes ici:
